LiCl-driven direct synthesis of mono-protected esters from long-chain dicarboxylic fatty acids.
Kuang. Yulong Y; Yang. Xiaohui X; Qin. Tianhong T; Wang. Jigui J; Guo. Paul P; Jiang. Chaozhe C
Key Findings
- LiCl addition dramatically improves mono‑ester selectivity over di‑ester formation
- A one‑step method using TFAA and LiCl efficiently creates mono‑tert‑butyl esters from long‑chain dicarboxylic acids
- The approach provides a cleaner route to intermediates needed for making tirzepatide and semaglutide
Practical Outcomes
- For most biohackers, this chemistry advance has little direct impact on personal use of tirzepide. It’s mainly useful for manufacturers or chemists looking to streamline drug‑production processes, not for dosing or performance‑enhancing protocols.
Summary
The paper describes a new lab chemistry trick to make a single‑ester version of long‑chain fatty acids, which are building blocks used when manufacturing drugs like tirzepatide, but it doesn’t give any new information about how the drug works, how to dose it, or how to use it for health benefits.
Abstract
A one-step mono-esterification method for long-chain dicarboxylic fatty acids [HO<sub>2</sub>C(CH<sub>2</sub>) <sub><i>n</i></sub> CO<sub>2</sub>H; <i>n</i> ≥ 14] was developed using TFAA (trifluoroacetic anhydride) and LiCl as esterification reagents. This approach was particularly effective for synthesizing mono <i>tert</i>-butyl esters, which are key intermediates in the production of segments of semaglutide and tirzepatide-two blockbuster drugs with their 2024 sales valued in billions of dollars. The addition of LiCl critically enhanced the monoester selectivity over diester formation. Mechanistic studies suggest that this selectivity originates from a shielding effect, where LiCl interacts with one terminal carboxylic acid group.
Study Information
pubmed
2025
2025-10-07T00:00:00.000Z
10.1039/d5ra04970a
31